Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-060278
Filing Date
2014-09-30
Accepted
2014-09-30 18:41:08
Documents
2
Period of Report
2014-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7373
2 POA DOCUMENT poa.txt EX-24.4_539807 2652
  Complete submission text file 0001209191-14-060278.txt   11602
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 141130778